{"id":"W2314443675","doi":"10.1097/aci.0000000000000165","title":"Clinically relevant outcome measures for new therapies of asthma using pharmaceutical and biologic agents","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Allergy and Clinical Immunology","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Asthma; Omalizumab; Intensive care medicine; Periostin; Quality of life (healthcare); Disease; Clinical trial; Immunology; Internal medicine; Immunoglobulin E","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00306433,0.001538307,0.004615269,0.003711391,0.0002384614,0.001436031,0.001510188,0.001539966,0.004080837],"category_scores_gemma":[0.005611923,0.0003890447,0.002111911,0.002918133,0.0007299807,0.00149982,0.0008906276,0.002557149,0.001642336],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001077214,"about_ca_system_score_gemma":0.001908459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001052522,"about_ca_topic_score_gemma":0.00149242,"domain_scores_codex":[0.9983149,0.0004369732,0.0004187622,0.0001949951,0.0005731559,0.0000613127],"domain_scores_gemma":[0.9963348,0.002322178,0.0006329342,0.00007089233,0.0005665205,0.00007262306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001662839,0.0000707049,0.0003574561,0.1083378,0.0007903941,0.00009886651,0.00004956947,0.0003133449,0.0006525943,0.002977818,0.02290152,0.8632837],"study_design_scores_gemma":[0.0001363195,0.0002719943,0.004443326,0.08891231,0.002490649,0.001349206,0.0001336467,0.000295956,0.0006693883,0.004044039,0.8971705,0.00008262456],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003819779,0.9991826,0.00007583842,0.0002371075,0.0001769362,0.00001144362,0.00002864525,0.000003365455,0.0002457999],"genre_scores_gemma":[0.0006143672,0.9983556,0.0002704058,0.0002858001,0.00024225,0.00002531516,0.00004866983,0.000001819831,0.0001557137],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004615269,"threshold_uncertainty_score":0.01620597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4741584306365029,"score_gpt":0.5559063717951328,"score_spread":0.08174794115862988,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}